Theratome Bio is a pre-clinical company developing a platform of cell-free biologics. The therapeutics cover multiple areas of unmet medical need, and offer advantages over cell-based therapies, including off-the-shelf administration, convenient freezer temperature storage and delivery, and immediate bioavailability. Current therapeutic areas under development are ischemic brain injury, concussion, acute kidney injury, and increasing the shelf life of donor organs and tissues.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 1800 N Capitol Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- theratomebio.com
- Keywords
- biotech, therapeutics, innovation, stroke, traumatic brain injury, concussion, acute kidney injury, organ transplant preservation.
- HQ
- Indianapolis, Indiana
Theratome Bio Questions
Theratome Bio's website is theratomebio.com
Theratome Bio's LinkedIn profile is https://www.linkedin.com/company/theratome-bio
Theratome Bio has
1 employees.
View email and phone details for 1
employees at Theratome Bio.
Theratome Bio's industry is
Biotechnology Research
Theratome Bio's top competitors are
Mohyi Labs,
Baroco Corporation,
Venndi,
Knowix,
Snrg Corporation,
Triumvira Immunologics, Inc.,
Customair,
Resq Pharma, Inc.,
Karmascore,
Central Texas Staffing Llc.
Theratome Bio's categories are Biotechnology Research
Theratome Bio's founding year is 2011
